Observational studyBMC emergency medicine2025
Drug-related emergency department visits in Qatar: a prospective cohort study.
Observational study in BMC emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMedication therapy is linked to increased risks and preventable adverse drug events (ADEs). ADEs significantly burden healthcare systems by raising hospitalization rates, emergency department (ED) visits, prolonged hospital stays, morbidity, and mortality. The main study objective was to determine the incidence, severity, and preventability of drug-related visits to the ED of two large governmental hospitals in Qatar.
methodsThis prospective observational cohort study was conducted in hospital EDs using systematic random sampling to select patients. Data were collected from electronic healthcare records and patient interviews. ED visits were assessed for ADEs using predesigned and tested tools.
resultsOne thousand cases were evaluated from November 2020 to January 2022. Of these, 178 (17.8%) were admitted due to ADEs, caused by 187 drug therapy problems (DTPs). The most common DTP was non-compliance with prescribed therapy (77; 41.17%). Over 50% of ADEs (98; 55.1%) were of moderate severity, and the majority (154; 86.5%) were preventable. Multivariate analysis identified female gender (OR 0.694; 95% CI 0.499–0.967) and the number of medications at admission (OR1.077; 95% CI 1.029–1.126) as independent predictors of ADE incidence.
conclusionsADEs were significant contributors to ED visits in Qatar with the majority being potentially preventable. It is essential to design interventions to improve patient adherence. Further studies assessing ED visits related to specific medication classes, as well as proposing solutions to minimize specific DTPs are needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.